Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Michelle Harris

1PUBLICATIONS

12CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Feb 24, 2025

ESR1 Y537S and D538G Mutations Drive Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer.

Chang-Ching A Lin, María Rosario Chica-Parrado, Nisha Unni

Pageof 1

Frequent Collaborators

1 joint publications

Chang-Ching A Lin

1 joint publications

María Rosario Chica-Parrado

1 joint publications

Nisha Unni

1 joint publications

Ellen Jaeger

1 joint publications

Yisheng V Fang

1 joint publications

Lei Guo

1 joint publications

Fabiana Napolitano

1 joint publications

Pamela Luna

1 joint publications

Calvin Chao

1 joint publications

Lin Xu

Frequent Collaborators

1 joint publications

Chang-Ching A Lin

1 joint publications

María Rosario Chica-Parrado

1 joint publications

Nisha Unni

1 joint publications

Ellen Jaeger

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos

Top Related Videos

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells <em>In Vitro</em> with a 2-step Dose-escalation Procedure

Published on : Aug 11, 2017

See more related videos